New anemia drug studied in kids with kidney disease
NCT ID NCT05682326
First seen Nov 11, 2025 · Last updated May 18, 2026 · Updated 32 times
Summary
This study tested a drug called daprodustat in children aged 3 months to under 18 years who have anemia due to chronic kidney disease. The goal was to see how the drug moves through the body and if it is safe. The study included children both on and off dialysis and lasted about 60 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANAEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
GSK Investigational Site
Aichi, 466-8650, Japan
-
GSK Investigational Site
Saitama, 330-8777, Japan
-
GSK Investigational Site
Tokyo, 162-8666, Japan
-
GSK Investigational Site
Yangsan, 50612, South Korea
Conditions
Explore the condition pages connected to this study.